Balance Risks and Benefits of Antithrombotic Combos in Atrial Fib

Antithrombotic combos for patients with atrial fib PLUS a coronary stent are a moving target...due to evolving evidence and stent technology.

The standard used to be "triple therapy"...an anticoagulant (warfarin, etc) plus TWO antiplatelets (aspirin and clopidogrel, etc).

But these combos are a tightrope walk...and risk of bleeding must be balanced against risk of embolic stroke, heart attack, or stent thrombosis.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote